 | Who Owns SCYNEXIS Inc (NASDAQ:SCYX)?
finance.yahoo.com - September 18 at 5:01 PM |
 | SCYNEXIS Inc (SCYX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - September 7 at 2:34 AM |
| SCYNEXIS Inc (SCYX) Expected to Post Quarterly Sales of $70,000.00
www.americanbankingnews.com - September 5 at 5:21 AM |
| -$0.20 Earnings Per Share Expected for SCYNEXIS Inc (SCYX) This Quarter
www.americanbankingnews.com - September 3 at 4:22 AM |
| SCYNEXIS, Inc. to Participate in Upcoming Investor Conferences
finance.yahoo.com - August 29 at 8:23 AM |
| SCYNEXIS Inc (SCYX) CEO Acquires $32,250.00 in Stock
www.americanbankingnews.com - August 27 at 10:22 AM |
 | SCYNEXIS misses by $0.06, misses on revenue
seekingalpha.com - August 10 at 8:15 AM |
| Scynexis (SCYX) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 8:15 AM |
| Scynexis: 2Q Earnings Snapshot
finance.yahoo.com - August 9 at 6:08 PM |
| SCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - August 9 at 6:08 PM |
| The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
finance.yahoo.com - July 18 at 4:53 PM |
 | Week Ahead In Pharmaceuticals - 7 Stocks To Watch
www.nasdaq.com - July 14 at 3:39 PM |
| SCYNEXIS: An Update On This ~$2 'Lottery Ticket'
seekingalpha.com - July 14 at 3:39 PM |
| Why Scynexis Stock Rose 16.4% Yesterday
finance.yahoo.com - July 12 at 4:49 PM |
| Biotech Analysis Central Pharma News: Pfizer's Unit Separation, BioCryst's Merger Collapses, Scynexis' Positive Mid-Stage Results
seekingalpha.com - July 12 at 8:15 AM |
| SCYNEXIS selects dose regimen for late-stage studies of antifungal SCY-078
seekingalpha.com - July 11 at 8:12 AM |
 | Scynexis (SCYX) Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in VVC
www.streetinsider.com - July 10 at 5:00 PM |
| SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis
finance.yahoo.com - July 10 at 5:00 PM |
| Complimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks
finance.yahoo.com - July 2 at 8:23 AM |
| SCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual Meeting
finance.yahoo.com - June 27 at 8:48 AM |
| Scynexis, Undervalued And Filling A Critical Need In The Antifungal Space
seekingalpha.com - June 26 at 5:20 PM |
| Form 8-K SCYNEXIS INC For: Jun 14
www.streetinsider.com - June 22 at 5:45 PM |
| SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018
finance.yahoo.com - June 14 at 8:18 AM |
| SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - June 11 at 5:14 PM |
| Your Daily Pharma Scoop: Scynexis Moves Up, Proteostasis Disappoints Investors, Cellectar Zooms
seekingalpha.com - June 11 at 8:12 AM |
| SCYNEXIS announces publication of early-stage SCY-078 data; shares up 2% premarket
seekingalpha.com - June 6 at 5:31 PM |
| SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - May 24 at 5:46 PM |
| Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks
finance.yahoo.com - May 24 at 8:15 AM |
| SCYNEXIS to Participate in a Panel at the 2018 BIO International Convention
finance.yahoo.com - May 23 at 5:40 PM |
| What’s Behind the 28% Hike in SCYNEXIS Stock Last Week?
finance.yahoo.com - May 22 at 8:16 AM |
| SCYNEXIS beats by $0.08, misses on revenue
seekingalpha.com - May 9 at 8:15 AM |
| Scynexis: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 8:14 AM |
| SCYNEXIS Reports First Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - May 8 at 5:45 PM |
| Roth Capital Assumes SCYNEXIS (SCYX) at Buy
www.streetinsider.com - May 8 at 8:12 AM |
 | Benzinga's Top Upgrades, Downgrades For May 7, 2018
www.benzinga.com - May 7 at 5:43 PM |
| UPDATE: HC Wainwright Starts SCYNEXIS (SCYX) at Buy
www.streetinsider.com - May 7 at 8:15 AM |
| Scynexis (SCYX) Granted FDA Fast Track & Qualified Infectious Disease Product Designation for Oral SCY-078
www.streetinsider.com - May 2 at 8:17 AM |
 | SCYNEXIS's Oral SCY-078 Receives FDA QIDP and Fast Track Designations for the Treatment of VVC and Prevention ...
www.prnewswire.com - May 1 at 5:21 PM |
| SCYNEXIS's Oral SCY-078 Receives FDA QIDP and Fast Track Designations for the Treatment of VVC and Prevention of Recurrent VVC
finance.yahoo.com - May 1 at 5:21 PM |
| SCYNEXIS Data Presentations at ECCMID 2018 Show SCY-078 Potent and Synergistic Antifungal Activity Against Aspergillus and Pneumocystis
finance.yahoo.com - April 23 at 8:12 AM |
| Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical ...
www.prnewswire.com - April 20 at 5:25 PM |
| Generic Drugs Stocks' Research Reports Released on Mylan, Momenta Pharma, Rigel Pharma, and SCYNEXIS
www.prnewswire.com - April 13 at 8:15 AM |
| SCYNEXIS to Present SCY-078 Data at the 28th European Congress of Clinical Microbiology and Infectious Disease ...
www.prnewswire.com - April 10 at 5:33 PM |
| SCYNEXIS to Present SCY-078 Data at the 28th European Congress of Clinical Microbiology and Infectious Disease (ECCMID)
finance.yahoo.com - April 10 at 8:19 AM |
| Form 4 SCYNEXIS INC For: Apr 02 Filed by: Macdonald Guy
www.streetinsider.com - April 5 at 10:04 AM |
| Form 4 SCYNEXIS INC For: Mar 29 Filed by: Angulo Gonzalez David
www.streetinsider.com - April 2 at 8:32 AM |
| SCYNEXIS to Present at the 17th Annual Needham Healthcare Conference - PR Newswire (press release)
www.prnewswire.com - March 22 at 8:21 AM |
| SCYNEXIS Presents Data at Superbugs and Superdrugs 2018 - PR Newswire (press release)
www.prnewswire.com - March 21 at 8:42 AM |
| SCYNEXIS to Present at the 17th Annual Needham Healthcare Conference
finance.yahoo.com - March 21 at 8:42 AM |
| SCYNEXIS Presents Data at Superbugs and Superdrugs 2018
finance.yahoo.com - March 20 at 5:21 PM |
